The paper aims to move “beyond paranoia”—that is, beyond the traditional focus on positive symptoms like delusions—to examine the neuropsychological and biological factors that drive cognitive heterogeneity within schizophrenia subtypes. The central premise is that schizophrenia is not a single cognitive entity; rather, distinct subtypes exist that differ in the severity and profile of cognitive deficits, and these differences have measurable neural and biological correlates.
